A Spotlight on Drug-Induced Vasculitis

•• Jennette JC, Falk RJ, Bacon PA, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1–11. https://doi.org/10.1002/art.37715. International Consensus guidelines on the classification of different vasculitides.

CAS  Article  PubMed  Google Scholar 

ten Holder SM, Joy MS, Falk RJ. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother. 2002;36(1):130–47. https://doi.org/10.1345/aph.1A124.

Article  PubMed  Google Scholar 

Wiik A. Drug-induced vasculitis. Curr Opin Rheumatol. 2008;20(1):35–9. https://doi.org/10.1097/BOR.0b013e3282f1331f.

Article  PubMed  Google Scholar 

•• Gao Y, Zhao MH. Review article: Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrol Carlton Vic. 2009;14(1):33–41. https://doi.org/10.1111/j.1440-1797.2009.01100.x. One of the earliest reviews focusing on drug induced-AAV.

CAS  Article  Google Scholar 

Ihle BU, Whitworth JA, Dowling JP, Kincaid-Smith P. Hydralazine and lupus nephritis. Clin Nephrol. 1984;22(5):230–8.

CAS  PubMed  Google Scholar 

McKinnon RA, Nebert DW. Possible role of cytochromes P450 in lupus erythematosus and related disorders. Lupus. 1994;3(6):473–8. https://doi.org/10.1177/096120339400300608.

CAS  Article  PubMed  Google Scholar 

Pendergraft WF, Niles JL. Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. Curr Opin Rheumatol. 2014;26(1):42–9. https://doi.org/10.1097/BOR.0000000000000014.

CAS  Article  PubMed  Google Scholar 

Deng C, Lu Q, Zhang Z, et al. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum. 2003;48(3):746–56. https://doi.org/10.1002/art.10833.

CAS  Article  PubMed  Google Scholar 

Russell GI, Bing RF, Jones JA, Thurston H, Swales JD. Hydralazine sensitivity: clinical features, autoantibody changes and HLA-DR phenotype. Q J Med. 1987;65(246):845–52.

CAS  PubMed  Google Scholar 

Magro CM, Momtahen S, Harp J. The distinctive histopathology of hydralazine-associated ANCA positive vasculitis: in vivo demonstration of NETosis. Eur J Dermatol EJD. 2017;27(1):91–2. https://doi.org/10.1684/ejd.2016.2881.

Article  PubMed  Google Scholar 

Irizarry-Caro JA, Carmona-Rivera C, Schwartz DM, Khaznadar SS, Kaplan MJ, Grayson PC. Brief Report: Drugs implicated in systemic autoimmunity modulate neutrophil extracellular trap formation. Arthritis Rheumatol Hoboken NJ. 2018;70(3):468–74. https://doi.org/10.1002/art.40372.

CAS  Article  Google Scholar 

•• Timlin H, Liebowitz JE, Jaggi K, Geetha D. Outcomes of hydralazine induced renal vasculitis. Eur J Rheumatol. 2018;5(1):5–8. https://doi.org/10.5152/eurjrheum.2017.17075. Important study evaluated the long-term renal outcomes in patients with HAV.

Article  PubMed  Google Scholar 

•• Yokogawa N, Vivino FB. Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis. Mod Rheumatol. 2009;19(3):338–47. https://doi.org/10.1007/s10165-009-0168-y. Extensive review compared hydralazine-induced lupus and hydralazine-associated AAV.

Article  PubMed  Google Scholar 

•• Choi HK, Merkel PA, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 2000;43(2):405–13. https://doi.org/10.1002/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5Retrospective study that determined the prevalence of exposure to hydralazine, propylthiouracil and other drugs among 30 patients with vasculitis and the highest titers of anti-MPO antibodies detected at the study site laboratory.

CAS  Article  PubMed  Google Scholar 

•• Kumar B, Strouse J, Swee M, Lenert P, Suneja M. Hydralazine-associated vasculitis: Overlapping features of drug-induced lupus and vasculitis. Semin Arthritis Rheum. 2018;48(2):283–7. https://doi.org/10.1016/j.semarthrit.2018.01.005. Important retrospective study described overlapping features between hydralazine-induced lupus and hydralazine associated AAV.

CAS  Article  PubMed  Google Scholar 

•• Aeddula NR, Pathireddy S, Ansari A, Juran PJ. Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary–renal syndrome. BMJ Case Rep. Published online November 8, 2018:bcr-2018–227161. https://doi.org/10.1136/bcr-2018-227161Extensive review of literature that described  pulmonary-renal syndrome related to HAV.

•• Almaaitah S, Yaseen K, Jin Y, Hajj-Ali R. Long term outcome of hydralazine-associated vasculitis. In: Vol 71. 2019. https://acrabstracts.org/abstract/long-term-outcome-of-hydralazine-associated-vasculitis/. Accessed 11 Apr 2022. Recent abstract of a retroscpective study done at a large vasculitis center presented at the American College of Rheumatology described long term outcomes of HAV.

Slot MC, Links TP, Stegeman CA, Tervaert JWC. Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: a long-term followup study. Arthritis Rheum. 2005;53(1):108–13. https://doi.org/10.1002/art.20927.

Article  PubMed  Google Scholar 

Gumà M, Salinas I, Reverter JL, et al. Frequency of antineutrophil cytoplasmic antibody in graves’ disease patients treated with methimazole. J Clin Endocrinol Metab. 2003;88(5):2141–6. https://doi.org/10.1210/jc.2002-021383.

CAS  Article  PubMed  Google Scholar 

Nakazawa D, Tomaru U, Suzuki A, et al. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculiti. Arthritis Rheum. 2012;64(11):3779–87. https://doi.org/10.1002/art.34619.

CAS  Article  PubMed  Google Scholar 

Lubin E. Antithyroid drugs. N Engl J Med. 2005;352(21):2246–7 (author reply 2246-2247).

CAS  Article  Google Scholar 

Chen YX, Zhang W, Chen XN, et al. Propylthiouracil-induced Antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis versus primary ANCA-associated renal vasculitis: a comparative study. J Rheumatol. 2012;39(3):558. https://doi.org/10.3899/jrheum.110931.

CAS  Article  PubMed  Google Scholar 

•• Yang J, Yao LP, Dong MJ, et al. Clinical characteristics and outcomes of propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis in patients with graves’ disease: a median 38-month retrospective cohort study from a single institution in China. Thyroid Off J Am Thyroid Assoc. 2017;27(12):1469–74. https://doi.org/10.1089/thy.2017.0468. Single retroscpective study reported clinical presenation and outcomes of propylthiouracil-induced AAV.

CAS  Article  Google Scholar 

Hasegawa J, Hoshino J, Sekine A, et al. Clinical and histological features of antineutrophil cytoplasmic antibody-associated vasculitis related to antithyroid drugs. Clin Nephrol. 2018;89(6):438–44. https://doi.org/10.5414/CN109364.

CAS  Article  PubMed  Google Scholar 

Gao Y, Chen M, Ye H, Yu F, Guo XH, Zhao MH. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis. Rheumatol Oxf Engl. 2008;47(10):1515–20. https://doi.org/10.1093/rheumatology/ken321.

CAS  Article  Google Scholar 

Lee KC, Ladizinski B, Federman DG. Complications associated with use of levamisole-contaminated cocaine: an emerging public health challenge. Mayo Clin Proc. 2012;87(6):581–6. https://doi.org/10.1016/j.mayocp.2012.03.010.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Rongioletti F, Ghio L, Ginevri F, et al. Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol. 1999;140(5):948–51. https://doi.org/10.1046/j.1365-2133.1999.02833.x.

CAS  Article  PubMed  Google Scholar 

Chang A, Osterloh J, Thomas J. Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther. 2010;88(3):408–11. https://doi.org/10.1038/clpt.2010.156.

CAS  Article  PubMed  Google Scholar 

Nitro L, Pipolo C, Fadda GL, et al. Distribution of cocaine-induced midline destructive lesions: systematic review and classification. Eur Arch Otorhinolaryngol. Published online February 9, 2022. https://doi.org/10.1007/s00405-022-07290-1

•• McGrath MM, Isakova T, Rennke HG, Mottola AM, Laliberte KA, Niles JL. Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol CJASN. 2011;6(12):2799–805. https://doi.org/10.2215/CJN.03440411. Important retroscpective study at a large vasculitis center described clinical characteristics, laboratory findings and outcomes of cocaine- induced AAV.

Article  PubMed  Google Scholar 

Néel A, Agard C, Hamidou M. Vasculitides induced by cocaine and/or levamisole. Joint Bone Spine. 2018;85(1):9–14. https://doi.org/10.1016/j.jbspin.2017.05.022.

Article  PubMed  Google Scholar 

Lood C, Hughes GC. Neutrophil extracellular traps as a potential source of autoantigen in cocaine-associated autoimmunity. Rheumatol Oxf Engl. 2017;56(4):638–43. https://doi.org/10.1093/rheumatology/kew256.

CAS  Article  Google Scholar 

Czuchlewski DR, Brackney M, Ewers C, et al. Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol. 2010;133(3):466–72. https://doi.org/10.1309/AJCPOPQNBP5THKP1.

Article  PubMed  Google Scholar 

Lötscher F, Krusche M, Ruffer N, Kubacki T, Person F, Kötter I. Cocaine-induced ANCA-associated renal disease: a case-based review. Rheumatol Int. 2019;39(11):2005–14. https://doi.org/10.1007/s00296-019-04410-9.

CAS  Article  PubMed  Google Scholar 

Chandra T, Tabanor-Gayle JA, Lakshminarayanan S. Adalimumab-induced anti-neutrophilic cytoplasmic antibody vasculitis: a rare complication of an increasingly common treatment. Cureus. 2019. https://doi.org/10.7759/cureus.5598.

Salerno SM, Ormseth EJ, Roth BJ, Meyer CA, Christensen ED, Dillard TA. Sulfasalazine pulmonary toxicity in ulcerative colitis mimicking clinical features of Wegener’s granulomatosis. Chest. 1996;110(2):556–9. https://doi.org/10.1378/chest.110.2.556.

CAS  Article  PubMed  Google Scholar 

Denissen NHAM, Peters JGP, Masereeuw R, Barrera P. Can sulfasalazine therapy induce or exacerbate Wegener’s granulomatosis? Scand J Rheumatol. 2008;37(1):72–4. https://doi.org/10.1080/03009740701607117.

CAS  Article  PubMed  Google Scholar 

Choi HK, Merkel PA, Niles JL. ANCA-positive vasculitis associated with allopurinol therapy. Clin Exp Rheumatol. 1998;16(6):743–4.

CAS  PubMed  Google Scholar 

Haroon M, Devlin J. A case of ANCA-associated systemic vasculitis induced by atorvastatin. Clin Rheumatol. 2008;27(Suppl 2):S75-77. https://doi.org/10.1007/s10067-008-1020-z.

Article  PubMed  Google Scholar 

Gadde S, Lee B, Kidd L, Zhang R. Antineutrophil cytoplasmic antibodies crescentic allograft glomerulonephritis after sofosbuvir therapy. World J Nephrol. 2016;5(6):547. https://doi.org/10.5527/wjn.v5.i6.547.

Article  PubMed  PubMed Central 

留言 (0)

沒有登入
gif